These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16824851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.
    Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J.
    Eur J Clin Pharmacol; 2005 Oct; 61(9):667-74. PubMed ID: 16151763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ, Rawal B, Khan NA, Yeramaneni S, Goldenberg N, Wang P.
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Class effects of statins in elderly patients with congestive heart failure: a population-based analysis.
    Rinfret S, Behlouli H, Eisenberg MJ, Humphries K, Tu JV, Pilote L.
    Am Heart J; 2008 Feb; 155(2):316-23. PubMed ID: 18215603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
    Brophy JM, Brassard P, Bourgault C.
    Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
    [Abstract] [Full Text] [Related]

  • 14. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

  • 15. Impact of adherence to statins on chronic heart failure in primary prevention.
    Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M.
    Br J Clin Pharmacol; 2008 Nov; 66(5):706-16. PubMed ID: 18754842
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
    Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT.
    Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.
    Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
    [Abstract] [Full Text] [Related]

  • 19. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S, Kaczmarek I, Delgado O, Schmöckel M, Reichart B, Meiser B.
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [Abstract] [Full Text] [Related]

  • 20. Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients.
    Faltaos DW, Urien S, Carreau V, Chauvenet M, Hulot JS, Giral P, Bruckert E, Lechat P.
    Fundam Clin Pharmacol; 2006 Jun; 20(3):321-30. PubMed ID: 16671968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.